Chapter 08 - Topical Anesthestics Flashcards

1
Q
  1. Eutectic mixtures have which of the following characteristics?
    a. The work more rapidly than most other topicals.
    b. They penetrate deeper into skin than mucosa.
    c. Their melting points exceed that of their ingredients acting alone.
    d. Their formulations facilitate deeper and more efficient penetration of tissue compared with their ingredients acting alone.
A

d. EUTECTIC = a substance that has a lower melting point than any of its ingredients (greek, eu - tektos/tekein = melt/thaw easily)
- lower melting points facilitate penetration through tissue barriers
- formulated primarily in base form so that they can provide anesthesia more rapidly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. Which of the following lists is most accurate when describing topical anesthetic uses?
    a. Before exposing radiographs, before injections, before placing retraction cord.
    b. Before dental hygiene thx and in subgingival tissues.
    c. In procedures confined to mucosa and before taking impressions.
    d. All of the above
A

d. all of the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. Which ONE of the following statements is INCORRECT regarding maximum recommended doses of topical anesthetics?
    a. The are sometimes difficult to track.
    b. MRDs are not always provided.
    c. Spray forms have easy-to-track dosing.
    d. Oraquix has easy-to-track dosing.
A

c. Metered sprays ae generally easier to track. Unmetered sprays are not.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. Generous quantities of topical and injected anesthesia have been administered, when the patient begins to shake and appears agitated and anxious. Is there a reason for concern?
    a. Yes, because these may be early signs of CNS depression.
    b. No, because this is a very nervous patient and he/she hates dental appointments.
    c. No, because the doses of injectable anesthetic were within safe guidelines.
    d. Yes, because the patient is a dental phobic.
A

a. Tremors and agitation may be early signs of CNS depression.
They are also reactions that occur in response to stress of dental appointments.
It is important to remain alert to the development of further signs and symptoms of CNS depression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. Topical anesthetic mixtures may be of benefit in all but which ONE of the following ways?
    a. Combinations may increase therapeutic ranges.
    b. Combinations may increase penetration depths.
    c. Mixtures may allow drugs to be used as topicals that are not suitable when used alone.
    d. Mixtures decrease the potential for adverse reaction.
A

d. Adding additional drugs does not decrease the potential for adverse reactions; it generally increases the potential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. All of the following statements are true regarding compounded drugs, EXCEPT:
    a. Compounded drugs are formulated for individuals for whom they are prescribed.
    b. Compounded drugs maybe used on other individuals as long as the use is the same as the original use.
    c. Compounded drugs may contain much larger quantities of drug compared with multiuse commercial preparations.
    d, Compounded topicals are dispensed by prescription
A

b. Compounded drugs, incl. compounded topicals, may only be used on individuals for whom they may have been prescribed.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. The predominantly base form of lidocaine topical anesthetic is safer than the predominantly hydrochloride salt.
A

A. True, the base form has less ability to be absorbed systemically.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. Dyclonine hydrochloride is an excellent and very durable topical anesthetic and belongs to which ONE of the following classes of anesthetic?
    a. Amide
    b. Ketone
    c. Ester
    D. None of the above
A

b. Dyclonine has a ketone linkage as opposed to amide or ester.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Q8-1: List uses of topical anesthetic drugs.

A

A8-1:
1. penetration site anesthesia prior to needle insertion
2. discomfort related to radiographic film placement,
3. periodontal evaluation and treatment,
4. procedures confined to superficial mucosa,
5. the placement of retraction cord and rubber dams (when anesthesia has not been established prior to placement)
6. controlling gag reflexes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Q8-2: Explain why it is difficult to determine the dose of topical anesthetics used.

A

A8-2:
- MDRs for many topical products do not exist
- difficulty determining how much was dispensed or absorbed (before being washed away in saliva)
- patches and metered sprays offer more precise calculations as do some single-dose application systems.
- Liquids and gels in multi-use containers and non-metered sprays present problems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Q8-3: What are compounding rules?

A

A8-3:
- developed by the FDA’s Modernization Act of 1997
- “The compounded product must be individually prescribed for an identified patient.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Q8-4: How are topical anesthetics commonly dispensed and applied?

A

A8-4: They may be dispensed as liquids, gels, creams, ointments, metered and un-metered sprays, and subgingival dual-phase systems.

Application methods include the use of cotton swabs, sprays, air injection systems, and subgingival delivery systems with blunt-tipped devices.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Q8-5: Discuss the use of metered spray topical anesthetics.

A

A8-5:
- significant benefit over unmetered sprays when considering toxicity
- some unmetered sprays call for depressing the nozzle only one-half second per application. This rather limited spray interval is difficult to accomplish clinically, and applications may routinely exceed the half-second interval.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Q8-6: Discuss the advantages of using a liquid to gel topical anesthetic.

A

A8-6:
- easily applied because of its liquid state at room temperature and its rapid transformation to a gel-like state once placed sub-gingivally.
- provides excellent tissue anesthesia and occasional pulpal anesthesia
- has wide margins of safety, a known MRD, and easily quantified volumes dispensed because packaged in cartridge form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Q8-7: Give examples of common topical anesthetic agents.

A

A8-7: Common topical anesthetic agents are: 1. benzocaine,
dyclonine hydrochloride,
lidocaine,
prilocaine,
tetracaine hydrochloride (only in mixtures)
butamben (only in mixtures)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Q8-8: Why is benzocaine poorly absorbed into the systemic circulation?

A

A8-8: Benzocaine exists in a nearly 100% base form.
poor systemic absorption => very low potential for systemic toxicity.

17
Q

Q8-9: What is the most commonly used concentration of benzocaine?

A

A8-9: The most commonly used concentration of benzocaine is 20%.

18
Q

Q8-10: What is the onset time, peak effect, and duration of benzocaine?

A

A8-10: Benzocaine
- onset (adequate topical effect): 30 seconds
- peak: 2 minutes
- duration: 5 to 15 minutes.

19
Q

Q8-11: Discuss the advantages of using a varnish preparation of benzocaine topical.

A

A8-11:
- forms an insoluble, white surface film upon contact with moist tissue.
= visible “target” when applied at an appropriate penetration site.
- durable, with time-release product available for up to 30 minutes
- remains in place until physically removed or until slowly dissolved.

20
Q

Q8-12: How is benzocaine metabolized?

A

A8-12: Benzocaine is metabolized by ester hydrolysis (via cholinesterase).

21
Q

Q8-13: What is the FDA pregnancy category for benzocaine?

A

A8-13: Benzocaine is in FDA Pregnancy Category C

22
Q

Q8-14: How is lidocaine formulated for topical use?

A

A8-14: The most common preparation of lidocaine topical is as an ointment in multi-use containers. It is also available in 2–5% concentrations primarily in liquid and gel forms

23
Q

Q8-15: What is the onset time and duration of lidocaine topical?

A

A8-15: Onset times vary between 2 and 10 minutes with an expected duration of 15 minutes.

24
Q

Q8-16: What is the MRD for lidocaine topical?

A

A8-16: The MRD for lidocaine topical is reported to be 200 mg.

25
Q

Q8-17: What is the onset and average duration of anesthesia for tetracaine?

A

A8-17: The onset of tetracaine is slow and variable, with peak effects taking up to 20 minutes. The average duration of anesthesia for tetracaine is 20–60 minutes.

26
Q

Q8-18: Name the three topical drugs combined in Cetacaine® topical anesthetic and provide their clinical properties.

A

A8-18: The topical anesthetic Cetacaine® contains:
14% benzocaine (short-acting, fast-onset),
2% tetracaine (long-acting, slow-onset), and
2% butamben (intermediate-acting, intermediate-onset).

27
Q

Q8-19: What are the benefits of eutectic mixtures of topical anesthetics?

A

A8-19:
- provide a more rapid onset on skin and
- a greater depth of topical anesthesia penetration on both skin and mucosa compared with any of the ingredients acting alone

28
Q

Q8-20: Give two examples of eutectic mixtures of local anesthetic drugs.

A

A8-20: Two common eutectic mixtures of local anesthetic drugs commercially available are EMLA® and Oraqix®.

29
Q

Q8-21: What drugs are contained in Oraqix®?

A

A8-21: Oraqix® is a mixture of lidocaine and prilocaine. It is formulated for intrapocket, subgingival application with a syringe type delivery system.

30
Q

Q8-22: What are the features that enhance the safety of Oraqix®?

A

A8-22: Features enhancing the safety of Oraqix include:
1) Low systemic toxicity with only 20% to 40% of the dispensed drug available systemically.
2) Ease of dose tracking compared to multi-dose packaging common with other topicals. (Standard calculation methods can be used with the 1.7 mL cartridges.)
3) A specialized safety collar prevents accidental placement of the cartridge into standard aspirating syringes, avoiding accidental submucosal injection of the drugs.

31
Q

Q8-23: Why is EMLA® useful in pediatric dentistry?

A

A8-23: In pediatric dentistry, EMLA® may provide complete pulpal anesthesia for some procedures due to its significant depth of penetration.

32
Q

Q8-24: Provide examples of local adverse reactions with the use of topical local anesthetic agents.

A

A8-24: Local reactions with topical agents include tissue sloughing, delayed hypersensitivity, redness, pain, and burning at the sites of application.

33
Q

Q8-25: What are possible systemic reactions of topical anesthetic overdose?

A

A8-25: Overdoses may manifest as mild CNS depression (restlessness, agitation, and increased heart rate) or more severe CNS and CVS depression (unconsciousness, convulsions, decreased force of myocardial contraction, respiratory collapse, and cardiovascular collapse).

34
Q

Q8-26: Discuss the advantage of jet injection devices.

A

A8-26: The greatest advantage of jet injector devices appears to arise from the ability to propel solutions into tissues at significant depths without the use of needles, deep enough at times to provide pulpal anesthesia. Jet injector devices also provide deeper topical anesthesia prior to needle penetration.

35
Q

Q8-27: Explain why EMLA® would be a good choice of topical anesthetic for Elena Gagarin.

A

A8-27: Some topical anesthetics such as EMLA® can provide greater depths of penetration compared with other topical anesthetics and do not usually require injections afterward in order to place comfortable rubber dam clamps.

36
Q

Cetacaine:
- Onset
- Duration:
- Max dose:

A
  • Onset: 30 sec
  • Duration: 30-60 min
  • Max dose:
  • no official MDR,
    – recommended by manufacturer 200mg (~0.2mL)
    – do not exceed 400mg (~0.4mL)
37
Q

Cetacaine spray dosing

A

1 sec spray ~ 200mg
recommended to spray for less than 1 sec
over 2 seconds is “excessive” and not recommended

38
Q

Dento Patch
- ingredients
- application
- warnings

A
  • ingredients: ea. patch = 46mg Lidocaine w/ 1.5mg available
  • application: “30 to dry, 30 to apply” (seconds)
    “remove at 15, stop at 40” (minutes)
  • warnings: do not apply to traumatize or septic tissue